The collaboration unites XenoSTART’s repository of clinically annotated Patient-Derived Xenograft (PDX) models with Minerva Imaging’s advanced molecular imaging and radionuclide therapy expertise, creating a single-source solution spanning discovery, translational research, and manufacturing.
Radionuclide Therapy | 06/10/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy